Australia
· Delayed Price · Currency is AUD Clinuvel Pharmaceuticals Statistics
Total Valuation
ASX:CUV has a market cap or net worth of AUD 518.60 million. The enterprise value is 321.10 million.
| Market Cap | 518.60M |
| Enterprise Value | 321.10M |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | Sep 5, 2024 |
Share Statistics
ASX:CUV has 50.01 million shares outstanding. The number of shares has decreased by -2.63% in one year.
| Current Share Class | 50.01M |
| Shares Outstanding | 50.01M |
| Shares Change (YoY) | -2.63% |
| Shares Change (QoQ) | -0.39% |
| Owned by Insiders (%) | 10.39% |
| Owned by Institutions (%) | 22.91% |
| Float | 41.32M |
Valuation Ratios
The trailing PE ratio is 13.48 and the forward PE ratio is 13.23. ASX:CUV's PEG ratio is 1.31.
| PE Ratio | 13.48 |
| Forward PE | 13.23 |
| PS Ratio | 5.70 |
| PB Ratio | 2.39 |
| P/TBV Ratio | 2.39 |
| P/FCF Ratio | 22.07 |
| P/OCF Ratio | 21.77 |
| PEG Ratio | 1.31 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.17, with an EV/FCF ratio of 13.67.
| EV / Earnings | 8.28 |
| EV / Sales | 3.53 |
| EV / EBITDA | 6.17 |
| EV / EBIT | 6.30 |
| EV / FCF | 13.67 |
Financial Position
The company has a current ratio of 17.37, with a Debt / Equity ratio of 0.00.
| Current Ratio | 17.37 |
| Quick Ratio | 16.37 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.03 |
| Interest Coverage | 11.55 |
Financial Efficiency
Return on equity (ROE) is 19.59% and return on invested capital (ROIC) is 16.01%.
| Return on Equity (ROE) | 19.59% |
| Return on Assets (ROA) | 14.22% |
| Return on Invested Capital (ROIC) | 16.01% |
| Return on Capital Employed (ROCE) | 22.83% |
| Revenue Per Employee | 5.69M |
| Profits Per Employee | 2.42M |
| Employee Count | 16 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 0.76 |
Taxes
In the past 12 months, ASX:CUV has paid 19.03 million in taxes.
| Income Tax | 19.03M |
| Effective Tax Rate | 32.92% |
Stock Price Statistics
The stock price has decreased by -32.57% in the last 52 weeks. The beta is 0.77, so ASX:CUV's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -32.57% |
| 50-Day Moving Average | 10.62 |
| 200-Day Moving Average | 12.05 |
| Relative Strength Index (RSI) | 52.91 |
| Average Volume (20 Days) | 106,484 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:CUV had revenue of AUD 91.02 million and earned 38.78 million in profits. Earnings per share was 0.77.
| Revenue | 91.02M |
| Gross Profit | 82.68M |
| Operating Income | 50.94M |
| Pretax Income | 57.81M |
| Net Income | 38.78M |
| EBITDA | 51.73M |
| EBIT | 50.94M |
| Earnings Per Share (EPS) | 0.77 |
Balance Sheet
The company has 198.22 million in cash and 715,377 in debt, giving a net cash position of 197.51 million or 3.95 per share.
| Cash & Cash Equivalents | 198.22M |
| Total Debt | 715,377 |
| Net Cash | 197.51M |
| Net Cash Per Share | 3.95 |
| Equity (Book Value) | 217.30M |
| Book Value Per Share | 4.34 |
| Working Capital | 214.46M |
Cash Flow
In the last 12 months, operating cash flow was 23.83 million and capital expenditures -332,527, giving a free cash flow of 23.49 million.
| Operating Cash Flow | 23.83M |
| Capital Expenditures | -332,527 |
| Free Cash Flow | 23.49M |
| FCF Per Share | 0.47 |
Margins
Gross margin is 90.83%, with operating and profit margins of 55.97% and 42.60%.
| Gross Margin | 90.83% |
| Operating Margin | 55.97% |
| Pretax Margin | 63.51% |
| Profit Margin | 42.60% |
| EBITDA Margin | 56.83% |
| EBIT Margin | 55.97% |
| FCF Margin | 25.81% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.48%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 0.48% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 6.46% |
| Buyback Yield | 2.63% |
| Shareholder Yield | 3.12% |
| Earnings Yield | 7.48% |
| FCF Yield | 4.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 12, 2010. It was a reverse split with a ratio of 0.1.
| Last Split Date | Nov 12, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
ASX:CUV has an Altman Z-Score of 25.58 and a Piotroski F-Score of 4.
| Altman Z-Score | 25.58 |
| Piotroski F-Score | 4 |